“…Concerning treatment-related factors: systemic therapy, oncoplastic surgery, surgical specimen weight, lymphadenectomy, re-excision, postoperative seroma or oedema, a sequential or simultaneous boost, administration of the boost dose, the boost modality, dose inhomogeneity, (electron) energy and total RT dose are described [10,[13][14][15][16]26]. As reported by Hammer, most of the prognostic clinicopathological variables highly correlate with the DVH parameters derived from the dose distribution: for example, administration of boost dose, boost modality, cup size and also BMI [15]. In our analysis, Spearman correlation tests showed no correlation between V55 and surgical specimen weight and a possible correlation between V55 and BMI with r ¼ À0.17 and p value .10.…”